Biomarkers in Lung Diseases : from Pathogenesis to Prediction to New Therapies Functional and molecular factors associated with TAPSE in hypoxic pulmonary hypertension

X Slaven Crnkovic,* Albrecht Schmidt,* Bakytbek Egemnazarov, Jochen Wilhelm, Leigh M. Marsh, Bahil Ghanim, Walter Klepetko, Andrea Olschewski, Horst Olschewski, and Grazyna Kwapiszewska Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria; Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center, German Center for Lung Research, Giessen, Germany; Department of Thoracic Surgery, Medical University of Vienna/Vienna General Hospital, Vienna, Austria; Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria; and Department of Experimental Anaesthesiology, Medical University of Graz, Graz, Austria

[1]  T. Kolb,et al.  Right Ventricular Angiogenesis is an Early Adaptive Response to Chronic Hypoxia‐Induced Pulmonary Hypertension , 2015, Microcirculation.

[2]  N. Weissmann,et al.  Pressure Overload Creates Right Ventricular Diastolic Dysfunction in a Mouse Model: Assessment by Echocardiography. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[3]  B. Ghanim,et al.  Biomarkers in Lung Diseases : from Pathogenesis to Prediction to New Therapies Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients , 2015 .

[4]  Sebastien Bonnet,et al.  A miR-208–Mef2 Axis Drives the Decompensation of Right Ventricular Function in Pulmonary Hypertension , 2015, Circulation research.

[5]  J. Voigt,et al.  Clinical value of echocardiographic Doppler-derived right ventricular dp/dt in patients with pulmonary arterial hypertension. , 2014, European heart journal cardiovascular Imaging.

[6]  D. Badesch,et al.  [Definitions and diagnosis of pulmonary hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[7]  J. Lumens,et al.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. , 2013, Journal of the American College of Cardiology.

[8]  F. Martinez,et al.  Pulmonary hypertension in chronic lung diseases. , 2013, Journal of the American College of Cardiology.

[9]  I. González-Álvaro,et al.  IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts. , 2013, Rheumatology.

[10]  M. Humbert,et al.  Non-invasive indices of right ventricular function are markers of ventricular-arterial coupling rather than ventricular contractility: insights from a porcine model of chronic pressure overload. , 2013, European heart journal cardiovascular Imaging.

[11]  W. Paulus,et al.  Right Ventricular Diastolic Impairment in Patients With Pulmonary Arterial Hypertension , 2013, Circulation.

[12]  M. Giacca,et al.  Macrophage MicroRNA-155 Promotes Cardiac Hypertrophy and Failure , 2013, Circulation.

[13]  D. Ross,et al.  Endothelin Axis Is Upregulated in Human and Rat Right Ventricular Hypertrophy , 2013, Circulation research.

[14]  A. Murphy,et al.  Interleukin-22 promotes fibroblast- mediated wound repair in the skin , 2012, The Journal of investigative dermatology.

[15]  A. Olschewski,et al.  Origin of neomuscularized vessels in mice exposed to chronic hypoxia , 2011, Respiratory Physiology & Neurobiology.

[16]  P. Fawcett,et al.  Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. , 2011, American journal of respiratory cell and molecular biology.

[17]  T. Ørntoft,et al.  Pressure Load: The Main Factor for Altered Gene Expression in Right Ventricular Hypertrophy in Chronic Hypoxic Rats , 2011, PloS one.

[18]  E. Smit,et al.  Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension , 2010, International journal of rheumatology.

[19]  T. Wibmer,et al.  Circulating biomarkers of tissue remodelling in pulmonary hypertension , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[20]  N. Westerhof,et al.  Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[21]  S. Gangemi,et al.  Is interleukin-22 a possible indicator of chronic heart failure's progression? , 2010, Archives of gerontology and geriatrics.

[22]  E. Halpern,et al.  Noninvasive Assessment of Murine Pulmonary Arterial Pressure: Validation and Application to Models of Pulmonary Hypertension , 2010, Circulation. Cardiovascular imaging.

[23]  C. Long,et al.  Chronic Pulmonary Artery Pressure Elevation Is Insufficient to Explain Right Heart Failure , 2009, Circulation.

[24]  P. O’Reilly,et al.  Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.

[25]  M. Anderson.  CaMKII and a failing strategy for growth in heart. , 2009, The Journal of clinical investigation.

[26]  D. Ornitz,et al.  Hedgehog signaling is critical for maintenance of the adult coronary vasculature in mice. , 2008, The Journal of clinical investigation.

[27]  M. Karamanoglu,et al.  Right ventricular pressure waveform and wave reflection analysis in patients with pulmonary arterial hypertension. , 2007, Chest.

[28]  T. Helle-Valle,et al.  Contraction pattern of the systemic right ventricle shift from longitudinal to circumferential shortening and absent global ventricular torsion. , 2007, Journal of the American College of Cardiology.

[29]  R. Schwartz,et al.  Independent requirements for Hedgehog signaling by both the anterior heart field and neural crest cells for outflow tract development , 2007, Development.

[30]  T. Abraham,et al.  Tricuspid annular displacement predicts survival in pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.

[31]  K. Krobert,et al.  Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice. , 2006, American journal of physiology. Heart and circulatory physiology.

[32]  Jeremy J. W. Chen,et al.  GENE EXPRESSION PROFILES IN HYPOXIC PRECONDITIONING USING CDNA MICROARRAY ANALYSIS: ALTERED EXPRESSION OF AN ANGIOGENIC FACTOR, CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 1 , 2005, Shock.

[33]  Naomi C Chesler,et al.  Linked mechanical and biological aspects of remodeling in mouse pulmonary arteries with hypoxia-induced hypertension. , 2005, American journal of physiology. Heart and circulatory physiology.

[34]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[35]  Terry Speed,et al.  Normalization of cDNA microarray data. , 2003, Methods.

[36]  P. Poole‐Wilson,et al.  Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. , 2003, The American journal of cardiology.

[37]  A. Torbicki,et al.  Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. , 2003, Journal of the American College of Cardiology.

[38]  G. Koch,et al.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.

[39]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[40]  S. Pestka,et al.  Identification, Cloning, and Characterization of a Novel Soluble Receptor That Binds IL-22 and Neutralizes Its Activity1 2 , 2001, The Journal of Immunology.

[41]  M. Frenneaux,et al.  Diastolic Ventricular Interaction and Ventricular Diastolic Filling , 2000, Heart Failure Reviews.

[42]  Y. Zou,et al.  Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* , 1999, The Journal of Biological Chemistry.

[43]  P. Baeuerle,et al.  Hypoxia Induces c-fos Transcription via a Mitogen-activated Protein Kinase-dependent Pathway* , 1997, The Journal of Biological Chemistry.

[44]  Peipei Ping,et al.  Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heart , 1996, Nature Medicine.

[45]  M. Marzilli,et al.  Performance of the failing and nonfailing right ventricle of patients with pulmonary hypertension. , 1979, The American journal of cardiology.

[46]  Simon Gibbs,et al.  [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2015, Kardiologia polska.

[47]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[48]  E. Ashley,et al.  The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. , 2005, Cardiovascular research.

[49]  L. Tavazzi,et al.  Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.

[50]  B. Groves,et al.  Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. , 1997, Circulation.

[51]  L. Carrier,et al.  Contractile proteins and sarcoplasmic reticulum calcium-ATPase gene expression in the hypertrophied and failing heart. , 1992, Basic Research in Cardiology.

[52]  E. Braunwald,et al.  Studies on the first derivative of the ventricular pressure pulse in man. , 1962, The Journal of clinical investigation.